- Home
- QTRX vs SLRN Comparison
QTRX vs SLRN Comparison
Compare QTRX & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- SLRN
- Stock Information
- Founded
- QTRX 2007
- SLRN 2020
- Country
- QTRX United States
- SLRN United States
- Employees
- QTRX N/A
- SLRN N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- SLRN Health Care
- Exchange
- QTRX Nasdaq
- SLRN Nasdaq
- Market Cap
- QTRX 201.7M
- SLRN 224.6M
- IPO Year
- QTRX 2017
- SLRN 2023
- Fundamental
- Price
- QTRX $5.15
- SLRN $2.20
- Analyst Decision
- QTRX Strong Buy
- SLRN Hold
- Analyst Count
- QTRX 4
- SLRN 5
- Target Price
- QTRX $18.25
- SLRN $9.60
- AVG Volume (30 Days)
- QTRX 764.8K
- SLRN 972.8K
- Earning Date
- QTRX 05-06-2025
- SLRN 05-12-2025
- Dividend Yield
- QTRX N/A
- SLRN N/A
- EPS Growth
- QTRX N/A
- SLRN N/A
- EPS
- QTRX N/A
- SLRN N/A
- Revenue
- QTRX $137,421,000.00
- SLRN N/A
- Revenue This Year
- QTRX $5.22
- SLRN $267.11
- Revenue Next Year
- QTRX $15.31
- SLRN N/A
- P/E Ratio
- QTRX N/A
- SLRN N/A
- Revenue Growth
- QTRX 12.30
- SLRN N/A
- 52 Week Low
- QTRX $4.67
- SLRN $1.85
- 52 Week High
- QTRX $19.18
- SLRN $7.25
- Technical
- Relative Strength Index (RSI)
- QTRX 36.29
- SLRN 40.59
- Support Level
- QTRX $5.03
- SLRN $2.10
- Resistance Level
- QTRX $5.73
- SLRN $2.32
- Average True Range (ATR)
- QTRX 0.52
- SLRN 0.19
- MACD
- QTRX -0.02
- SLRN -0.03
- Stochastic Oscillator
- QTRX 21.43
- SLRN 18.58
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.